Search results

• Finished

  A Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System with Healthcare Professionals and Adult Subjects with Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone)

  Shergill, S. (Primary Investigator)

  8/06/2018 → 31/08/2018

  Project: Research

• Quantitative EEG correlates of visuo-spatial working memory in schizophrenia

  Shergill, S. (Primary Investigator)

  British Council

  28/02/2018 → 31/03/2019

  Project: Research

• Patient subjective well-being and switching of antipsychotic medication in schizophrenia - a naturalistic study.

  Shergill, S. (Primary Investigator) & Gilleen, J. (Co-Investigator)

  1/02/2016 → 31/07/2018

  Project: Research

• Using Structural and Functional Connectivity Features for Predicting Treatment Response in Psychosis

  Shergill, S. (Primary Investigator)

  1/01/2016 → 31/12/2017

  Project: Research

• Stratified medicine for cognition in schizophrenia: A proof-of-concept study with a7-nicotinic receptor agonists

  Michalopoulou, P. (Primary Investigator), Kapur, S. (Co-Investigator) & Shergill, S. (Co-Investigator)

  1/01/2016 → 31/12/2019

  Project: Research

• Neurostimulation-enhanced Behavioural Remediation of Social Cognition in Schizophrenia

  Mitchell, R. (Primary Investigator) & Shergill, S. (Co-Investigator)

  Brain and Behavior Research Foundation

  1/11/2015 → 31/10/2017

  Project: Research

• Cognitive Bias Modification for Paranoia: A novel attempt to treat paranoid delusions

  Yiend, J. (Primary Investigator), McGuire, P. (Co-Investigator), Peters, E. (Co-Investigator), Shergill, S. (Co-Investigator) & Stahl, D. (Co-Investigator)

  NIHR National Institute For Health & Care Research

  14/09/2015 → 30/11/2019

  Project: Research

• Neurostimulation-enhanced Behavioural Remediation of Social Cognition in Schizophrenia

  Mitchell, R. (Primary Investigator) & Shergill, S. (Co-Investigator)

  1/09/2015 → 31/08/2016

  Project: Research

• Development of a computational model to characterise the formation of trust and paranoia during human social interaction - an fMRI study.

  Gilleen, J. (Primary Investigator) & Shergill, S. (Co-Investigator)

  British Academy

  1/08/2015 → 1/03/2017

  Project: Research

• Event-related potentials to predict cognitive response to a7-nicotinic receptor agonists: a proof-of-concept study in schizophrenia

  Shergill, S. (Primary Investigator), Kapur, S. (Co-Investigator) & Michalopoulou, P. (Co-Investigator)

  1/05/2015 → 30/04/2019

  Project: Research

• Intranasal oxytocin for prodromal psychosis

  Fusar-Poli, P. (Primary Investigator), DO NOT USE, P. (Co-Investigator), McGuire, P. (Co-Investigator), Morrison, P. (Co-Investigator), Shergill, S. (Co-Investigator) & Williams, S. (Co-Investigator)

  1/05/2015 → 30/04/2019

  Project: Research

• Intranasal Oxytocin and Social Cognition In People At Ultra High Risk For Psychosis: Preliminary Study

  Fusar-Poli, P. (Primary Investigator), DO NOT USE, P. (Co-Investigator), McGuire, P. (Co-Investigator), Shergill, S. (Co-Investigator) & Williams, S. (Co-Investigator)

  1/05/2015 → 30/04/2018

  Project: Research

• Cognitive Bias Modification for Paranoia: A novel attempt to treat paranoid delusions

  Yiend, J. (Primary Investigator), McGuire, P. (Co-Investigator), Peters, E. (Co-Investigator), Shergill, S. (Co-Investigator), Stahl, D. (Co-Investigator) & academic, A. (Co-Investigator)

  1/04/2015 → 31/03/2018

  Project: Research

• A Double-Blind, Randomized, Placebo-Controlled Trial of Artesunate as an Add-on Therapy to Antipsychotic Medication in Treatment-refractory Schizophrenia patients

  Shergill, S. (Primary Investigator) & Mouchlianitis, E. (Co-Investigator)

  1/04/2015 → 1/09/2016

  Project: Research

• Two steps at a time approach to ameliorate cognitive deficits in schizophrenia

  Shergill, S. (Primary Investigator)

  31/10/2014 → 30/09/2015

  Project: Research

• Real time fMRI neurofeedback as a treatment for auditory hallucinations. A proof of concept study

  DO NOT USE, P. (Primary Investigator), Barker, G. (Co-Investigator), Giampietro, V. (Co-Investigator), McGuire, P. (Co-Investigator) & Shergill, S. (Co-Investigator)

  MRC Medical Research Council

  1/09/2014 → 30/11/2016

  Project: Research

• Evaluation of real time fMRI neurofeedback as a treatment for auditory hallucinations

  DO NOT USE, P. (Primary Investigator), Barker, G. (Co-Investigator), Giampietro, V. (Co-Investigator), McGuire, P. (Co-Investigator) & Shergill, S. (Co-Investigator)

  1/09/2014 → 1/09/2015

  Project: Research

• MICA - Neurophysiological basis of effects of oxytocin on emotional and social dysfunction and symptoms in people at ultra high risk of psychosis

  Fusar-Poli, P. (Primary Investigator), DO NOT USE, P. (Co-Investigator), McGuire, P. (Co-Investigator), Morrison, P. (Co-Investigator), Shergill, S. (Co-Investigator) & Williams, S. (Co-Investigator)

  1/04/2014 → 1/04/2018

  Project: Research

• Long Term Safety and Efficacy of ABT126 in Subjects with Schizophrenia: A Double Blind Extension Study for Subjects Completing Study M10-855

  Shergill, S. (Primary Investigator) & Brittain, P. (Co-Investigator)

  27/03/2014 → 31/07/2015

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled, 3-period, Proof of Mechanism, Cross-Over Study of Roflumilast (100 or 250 ug) administered up to Steady State to Evaluate the Effects of Add-on Roflumilast to Second Generation Antipsychotics

  Shergill, S. (Primary Investigator), Ffytche, D. (Co-Investigator), Gilleen, J. (Co-Investigator), Mehta, M. (Co-Investigator) & Williams, S. (Co-Investigator)

  Takeda Global R&D Centre (Europe) Ltd

  13/01/2014 → 31/01/2015

  Project: Research

• A Randomized, Double-Blind, Placebo Controlled, 3-period, Proof of Mechanism, Cross-Over Study of Roflumilast Administered up to Steady State to Evaluate the Effects of Add-on Roflumilast to Second Generation Antipsychotics on Cognitive Impairment

  Shergill, S. (Primary Investigator)

  Takeda Global R&D Centre (Europe) Ltd

  13/01/2014 → 1/12/2014

  Project: Research

• A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects

  Shergill, S. (Primary Investigator)

  Forum Pharmaceuticals Inc.

  16/12/2013 → 31/10/2014

  Project: Research

• Systemic and Clinical Research on Anxiety and Mood - SCREAM

  Shergill, S. (Primary Investigator)

  1/10/2013 → 30/09/2017

  Project: Research

• Forward-model deficits in treatment-resistant psychosis

  White, T. (Primary Investigator) & Shergill, S. (Co-Investigator)

  1/10/2013 → 30/09/2015

  Project: Research

• Developmental biomarkers of psychotic-like experiences in the healthy adolescent population

  Papanastasiou, E. (Primary Investigator), McGuire, P. (Co-Investigator), Schumann, G. (Co-Investigator) & Shergill, S. (Co-Investigator)

  1/08/2013 → 31/07/2016

  Project: Research

• Investigating decision making under single-dose oxytocin in schizophrenia

  Shergill, S. (Primary Investigator) & Wigton, R. (Co-Investigator)

  1/04/2013 → 1/04/2016

  Project: Research

• Developmental biomarkers of psychotic-like experiences in the healthy adolescent population

  Shergill, S. (Primary Investigator) & Papanastasiou, E. (Co-Investigator)

  1/04/2013 → 31/03/2016

  Project: Research

• Cognitive Bias Modification for Paranoia: A novel attemp to treat paranoid delusions

  Yiend, J. (Primary Investigator), McGuire, P. (Co-Investigator), Shergill, S. (Co-Investigator), Stahl, D. (Co-Investigator) & academic, A. (Co-Investigator)

  1/04/2013 → 31/03/2017

  Project: Research

• Mechanism Underlying Treatment Responses in Psychosis

  Shergill, S. (Primary Investigator)

  EC European Commission

  1/03/2013 → 30/11/2018

  Project: Research

• SCREAM

  Shergill, S. (Primary Investigator)

  1/01/2013 → 31/12/2015

  Project: Research

• Predicting treatment resistance in psychosis

  Shergill, S. (Primary Investigator) & Williams, S. (Co-Investigator)

  1/01/2013 → 31/12/2017

  Project: Research

• SCREAM

  Shergill, S. (Primary Investigator)

  1/01/2013 → 31/12/2015

  Project: Research

• Mechanisms underlying treatment response in psychosis - MUTRIPS

  Shergill, S. (Primary Investigator)

  1/12/2012 → 30/11/2017

  Project: Research

• MECHANISMS UNDERLYING TREATMENT RESPONSE IN PSYCHOSIS – MUTRIPS

  Shergill, S. (Primary Investigator)

  1/12/2012 → 30/11/2017

  Project: Research

• Mechanisms underlying treatment response in pychosis - MUTRIPS (STARTER)

  Shergill, S. (Primary Investigator)

  1/12/2012 → 30/11/2017

  Project: Research

• A prospective neuroimaging and neuropsychological study of adolescent aged 18 to 29 with psychotic-like experiences

  Shergill, S. (Primary Investigator) & Campbell, A. (Co-Investigator)

  1/07/2012 → 1/07/2018

  Project: Research

• A prospective neuroimaging and neuropsychological study of adolescents aged 18 to 19 with psychotic-like experiences.

  Shergill, S. (Primary Investigator) & academic, A. (Co-Investigator)

  1/07/2012 → 1/07/2018

  Project: Research

• NIHR Research Professorship

  Shergill, S. (Primary Investigator) & Williams, S. (Co-Investigator)

  1/03/2012 → 28/02/2017

  Project: Research

• A study improvig cognition in shizophrenia using cognitive training and non-invasive brain stimulation

  Shergill, S. (Primary Investigator), Kapur, S. (Co-Investigator) & Michalopoulou, P. (Co-Investigator)

  2/01/2012 → 31/01/2014

  Project: Research

• Examining the neural basis of perseption and decision-making in schizophrenia

  Shergill, S. (Primary Investigator)

  1/10/2011 → 30/09/2015

  Project: Research

• Clarifying the mechanism behind treatment-resistant psychosis

  Shergill, S. (Primary Investigator)

  1/07/2011 → 30/06/2016

  Project: Research

• A pilot study of improving cognition in schizophrenia using non-invasive brain stimulation.

  Shergill, S. (Primary Investigator)

  1/05/2011 → 30/04/2013

  Project: Research

• Levodopa as an add-on treatment for enhancing cognitive performance in schizophrenia: A randomised, controlled, pilot clinical trial

  Kapur, S. (Primary Investigator), Michalopoulou, P. (Co-Investigator) & Shergill, S. (Co-Investigator)

  1/04/2011 → 31/03/2013

  Project: Research

• Oxytocin effects on social decision making in schizophrenia

  Shergill, S. (Primary Investigator) & Williams, S. (Co-Investigator)

  1/01/2011 → 31/12/2013

  Project: Research

• Perception and decision making in schizophrenia.

  Shergill, S. (Primary Investigator) & Williams, S. (Co-Investigator)

  MRC Medical Research Council

  18/10/2010 → 17/06/2014

  Project: Research

• Clinical Placement Scheme

  Yiend, J. (Primary Investigator), Kravariti, J. (Co-Investigator), Nosarti, C. (Co-Investigator), Shergill, S. (Co-Investigator) & Tchanturia, K. (Co-Investigator)

  Maudsley Charity

  1/09/2010 → 30/04/2013

  Project: Research

• Levodopa as an add-on treatment for enhancing cognitive performance in schizophrenia: a randomised, controlled, clinical trial.

  Kapur, S. (Primary Investigator) & Shergill, S. (Co-Investigator)

  1/09/2010 → 31/08/2013

  Project: Research

• Nerual circuits and landscapes. A visual decoding of the Neuroscience of psychosis

  Shergill, S. (Primary Investigator)

  1/01/2010 → 1/06/2011

  Project: Research

• Attention to negative Information in anxiety and psychosis

  Shergill, S. (Primary Investigator) & Yiend, J. (Co-Investigator)

  1/01/2010 → 31/12/2012

  Project: Research

• Deficits in processing of sensory context associated with schizophrenia

  Shergill, S. (Primary Investigator) & Williams, S. (Co-Investigator)

  Wellcome Trust

  1/12/2009 → 30/11/2013

  Project: Research